These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2420632)

  • 1. Thyrotropin-releasing hormone (TRH) counteracts neuronal damage induced by a substance P antagonist.
    Freedman J; Hökfelt T; Jonsson G; Post C
    Exp Brain Res; 1986; 62(1):175-8. PubMed ID: 2420632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical and behavioral analysis of spinal lesions induced by a substance P antagonist and protection by thyrotropin releasing hormone.
    Freedman J; Hökfelt T; Post C; Brodin E; Sundström E; Jonsson G; Terenius L; Leander S; Fischer JA; Verhofstad A
    Exp Brain Res; 1989; 74(2):279-92. PubMed ID: 2466686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoconstrictor effects in spinal cord of the substance P antagonist [D-Arg, D-Trp7,9 Leu11]-substance P (Spantide) and somatostatin and interaction with thyrotropin releasing hormone.
    Freedman J; Post C; Kåhrström J; Ohlen A; Mollenholt P; Owman C; Alari L; Hökfelt T
    Neuroscience; 1988 Oct; 27(1):267-78. PubMed ID: 2462190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance P antagonist-induced spinal cord vasoconstriction: effects of thyrotropin-releasing hormone and substance P agonists.
    Helke CJ; Phillips ET
    Peptides; 1988; 9(6):1307-15. PubMed ID: 2470064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRH fails to antagonize the acute paralytic effects of intrathecal dynorphin A and substance P antagonists in the rat.
    Martinez-Arizala A; Long JB; Holaday JW
    Brain Res; 1988 Nov; 473(2):385-8. PubMed ID: 2466528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intrathecal proctolin administration on the behaviour evoked by the thyrotrophin-releasing hormone (TRH) analogue (RX 77368) and the indoleamine, TRH, substance P and calcitonin gene-related peptide levels and choline acetyltransferase activity in the rat spinal cord.
    Fone KC; Johnson JV; Bennett GW; Marsden CA
    Brain Res; 1988 Sep; 460(1):22-8. PubMed ID: 2464406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinociceptive and neurotoxic actions of substance P analogues in the rat's spinal cord after intrathecal administration.
    Post C; Paulsson I
    Neurosci Lett; 1985 Jun; 57(2):159-64. PubMed ID: 2412191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Hydroxytryptamine-thyrotropin releasing hormone interactions in the spinal cord: effects on parameters of sexual behaviour in the male rat.
    Hansen S; Svensson L; Hökfelt T; Everitt BJ
    Neurosci Lett; 1983 Dec; 42(3):299-304. PubMed ID: 6420733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substance P in the lumbar spinal cord of the rat affects the motor response to 5-HTP and TRH.
    Tremblay LE; Maheux R; Bédard PJ
    Neuropharmacology; 1986 Apr; 25(4):419-24. PubMed ID: 2423910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antinociceptive and substance P antagonistic effects of intrathecally injected spantide II in rat: no signs of motor impairment or neurotoxicity.
    Wiesenfeld-Hallin Z; Xu XJ; Kristensson K; Håkanson R; Feng DM; Folkers K
    Regul Pept; 1990 Jun; 29(1):1-11. PubMed ID: 1697080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the toxicity of subarachnoid clonidine, guanfacine, and a substance P-antagonist on rat spinal cord and nerve roots: light and electron microscopic observations after chronic intrathecal administration.
    Gordh T; Post C; Olsson Y
    Anesth Analg; 1986 Dec; 65(12):1303-11. PubMed ID: 2430489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a tachykinin antagonist on a nociceptive reflex in the isolated spinal cord-tail preparation of the newborn rat.
    Otsuka M; Yanagisawa M
    J Physiol; 1988 Jan; 395():255-70. PubMed ID: 2457677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and chronic effects of intrathecal galanin on behavioural and biochemical markers of spinal motor function in adult rats.
    Fone KC; Dixon DM
    Brain Res; 1991 Mar; 544(1):118-25. PubMed ID: 1713112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal effects of chronic intrathecal administration of the thyrotrophin-releasing hormone analogue (CG 3509) in rats.
    Fone KC; Dix P; Tomlinson DR; Bennett GW; Marsden CA
    Brain Res; 1988 Jul; 455(1):157-61. PubMed ID: 2458166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D-Arg1, D-Trp7,9, Leu11-substance P (spantide) does not antagonize substance P-induced hyperexcitability of the nociceptive flexion withdrawal reflex in the rat.
    Wiesenfeld-Hallin Z; Duranti R
    Acta Physiol Scand; 1987 Jan; 129(1):55-9. PubMed ID: 2436439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of thyrotropin-releasing hormone on Na(+)-K(+)-Adenosine triphosphatase activity following experimental spinal cord trauma.
    Baykal S; Ceylan S; Usul H; Aktürk F; Değer O
    Neurol Med Chir (Tokyo); 1996 May; 36(5):296-9. PubMed ID: 8710051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of 5-HT2 receptors in the behaviours produced by intrathecal administration of selected 5-HT agonists and the TRH analogue (CG 3509) to rats.
    Fone KC; Johnson JV; Bennett GW; Marsden CA
    Br J Pharmacol; 1989 Mar; 96(3):599-608. PubMed ID: 2470455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic thyrotropin-releasing hormone decreases the affinity and increases the number of its own receptor in the spinal cord.
    Prasad C; Spahn SA
    Neurosci Lett; 1989 Sep; 103(3):309-13. PubMed ID: 2554214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyrotropin releasing hormone (TRH) modified excitability of spinal cord dorsal horn cells.
    Jackson DA; White SR
    Neurosci Lett; 1988 Oct; 92(2):171-6. PubMed ID: 2903474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrathecal substance P and galanin attenuate TRH analogue-induced wet-dog shake behaviour.
    Dixon DM; Fone KC; Bennett GW; Marsden CA
    Br J Pharmacol; 1989 Dec; 98 Suppl():829P. PubMed ID: 2482111
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.